Brookfield Wealth Solutions Ltd., through its subsidiaries, provides retirement services, wealth protection products, and capital solutions to individuals and institutions. It operates through Annuities, Property and Casualty (P&C), Life Insurance segments. The Annuities segment offers retail and institutional annuities, including fixed index, fixed rate, single premium immediate, and variable annuities, as well as pension risk transfer. The P&C segment provides property and specialty insurance products casualty insurance comprising specialty casualty, construction defect, general liability, commercial multi-peril, workers compensation, product and environmental liability, and auto liability. The Life Insurance segment offers whole life, universal life, and variable universal life insurance products. The company was formerly known as Brookfield Reinsurance Ltd. and changed its name to Brookfield Wealth Solutions Ltd. in September 2024. Brookfield Wealth Solutions Ltd. was incorporated in 2020 and is headquartered in Pembroke, Bermuda.

Brookfield Wealth Solutions Ltd.

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE, with a price target of $115.00. According to ...

BioNTech SE (BNTX) Receives a Buy from Morgan Stanley

DZ BANK AG analyst Peter Spengler maintained a Hold rating on Brenntag AG yesterday. The company’s shares closed last Wednesday at €60.60. Accordin...

DZ BANK AG Remains a Hold on Brenntag AG (0MPT)

Pfizer Inc ($PFE), Biontech Se Sponsored Adr ($BNTX) announced an update on their ongoing clinical study. The new phase 4 study from BioNTech SE an...

Pfizer and BioNTech Advance Variant-Adapted COVID-19 Booster in New Phase 4 Study

Pfizer Inc ($PFE), Biontech Se Sponsored Adr ($BNTX) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) and BioNTech SE (BNTX) ...

Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update

Wells Fargo analyst maintained a Buy rating on BioNTech SE today and set a price target of $140.00. In addition to Wells Fargo, BioNTech SE also re...

Wells Fargo Remains a Buy on BioNTech SE (BNTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pacira Pharmaceuticals (PCRX), BioNTech SE (BNTX) an...

Analysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX), BioNTech SE (BNTX) and Henry Schein (HSIC)

Jefferies analyst Akash Tewari maintained a Buy rating on BioNTech SE today and set a price target of $138.00. According to TipRanks, Tewari is a 5...

Jefferies Sticks to Their Buy Rating for BioNTech SE (BNTX)

Bernstein analyst Jeffrey Walch maintained a Hold rating on BioNTech SE today and set a price target of $96.00. According to TipRanks, Walch is a 3...

Bernstein Sticks to Their Hold Rating for BioNTech SE (BNTX)

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE today and set a price target of $119.00. According to TipRanks, Flynn i...

Brenntag AG received a Hold rating and price target from DZ BANK AG analyst Peter Spengler today. According to TipRanks, Spengler is a 4-star analy...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BNT	$42.86	-2.21%	10.23K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BNT	$42.86	-2.2%	10.23K
3
4
5
6

BNT

Get Brookfield Wealth Solutions Ltd. Data in Excel

Get Brookfield Wealth Solutions Ltd. Data in Excel